BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Prognosis
6392 results:

  • 1. Association between advanced lung cancer inflammation index and all-cause and cardiovascular mortality among stroke patients: NHANES, 1999-2018.
    Chen X; Hong C; Guo Z; Huang H; Ye L
    Front Public Health; 2024; 12():1370322. PubMed ID: 38699426
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
    Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
    J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of log odds of positive lymph nodes with survival in patients with small cell lung cancer: Results from the SEER database.
    Gao T; Chang Y; Yue H
    Clinics (Sao Paulo); 2024; 79():100369. PubMed ID: 38696974
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Interpretation of global lung cancer statistics].
    Cai L; Zhu CX; Zhang XL; Fang Y; Yang HY; Guo LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):585-590. PubMed ID: 38678357
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
    Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
    Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Limited resection is comparable to lobectomy for tumor size ≤ 2 cm pulmonary invasive mucinous adenocarcinoma.
    Lin W; Su H; Xie H; Xu L; Wang T; Wang L; Hu X; Zhao D; Zhu Y; Wang H; Jiang G; Xie D; Chen C;
    World J Surg Oncol; 2024 Apr; 22(1):109. PubMed ID: 38664816
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
    Han R; Guo H; Shi J; Zhao S; Jia Y; Liu X; Liu Y; Cheng L; Zhao C; Li X; Zhou C
    BMC Med; 2024 Apr; 22(1):174. PubMed ID: 38658988
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The endonuclease FEN1 mediates activation of STAT3 and facilitates proliferation and metastasis in breast cancer.
    Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
    Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial.
    Mao J; Ni J; Chu L; Chu X; Xu D; Yang X; Zhu Z
    Radiat Oncol; 2024 Apr; 19(1):47. PubMed ID: 38610031
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.
    Xu Y; Zhang Q; Chen Z; Yang S; Chen H; Xiao X; Jiang H
    BMC Pulm Med; 2024 Apr; 24(1):174. PubMed ID: 38609918
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
    Cao XN; Li Z; Wang QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
    [No Abstract]    [Full Text] [Related]  

  • 15. [Clinical characteristics and prognosis analysis of pulmonary sarcomatoid carcinoma].
    Feng XY; Chen MJ; Xu Y; Zhong W; Liu XY; Gao XX; Zhao J; Wang MZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):319-324. PubMed ID: 38599806
    [No Abstract]    [Full Text] [Related]  

  • 16. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
    Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
    BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
    Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
    Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
    PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.
    Oh Y; Yoon SM; Lee J; Park JH; Lee S; Hong T; Chung LI; Sudhaman S; Riddell T; Palsuledesai CC; Krainock M; Liu MC; Chae YK
    Thorac Cancer; 2024 May; 15(13):1095-1102. PubMed ID: 38558374
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 320.